Spotlight
Commentary
Cultural Corner
Psychiatric Practice
Series
News
Job Board
CME/CE
Partners
Editorial
Subscribe
Video
Investigational Treatment Shows Potential to Supress Memory Loss
Author(s):
Aaron Burstein, PharmD, shares details from a scientific presentation at the Alzheimer's Association International Conference.
MENTAL HEALTH MINUTE
Aaron Burstein, PharmD, senior vice president of vTv Therapeutics, shares the history and current status of development of azeliragon for the treatment of dementia and diabetes, including results recently presented at the 2020 Alzheimer's Association International Conference.
Video Player is loading.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Related Videos
Poster at APA Annual Meeting Explores the Use of GLP-1 Agonists for Antipsychotic-Associated Metabolic Issues
Posdinemab: Addressing the Unmet Need in Alzheimer Disease
Optimizing Treatment for ADHD
New Biomarker Study of Rapid-Acting Treatment for Acute Depression
“If You Ask Me My Name”
New Year, New Look
Taking and Leveraging In-Depth Work Histories: Educating the Future of Psychiatry
An American Sunrise
How Full is Your New Year Glass This Year?
Clinical Advances in Treating PPD on the Horizon
Related Content
